Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The Angels Initiative

Stroke prevention

  Lung Cancer

  Free Subscription

Articles published in Genes Chromosomes Cancer

Retrieve available abstracts of 6 articles:
HTML format

Single Articles

    October 2022
  1. DERMAWAN JK, Torrence D, Lee CH, Villafania L, et al
    EWSR1::YY1 fusion positive peritoneal epithelioid mesothelioma harbors mesothelioma epigenetic signature: Report of 3 cases in support of an emerging entity.
    Genes Chromosomes Cancer. 2022;61:592-602.
    PubMed     Abstract available

    April 2022
  2. WANG W, Gu X, Si J, Pu X, et al
    Treatment outcomes and prognosis of patients with primary and acquired BRAF-mutated non-small cell lung cancer: a multicenter retrospective study.
    Genes Chromosomes Cancer. 2022 Apr 8. doi: 10.1002/gcc.23043.
    PubMed     Abstract available

  3. EL ZEIN S, Djeroudi L, Reynaud S, Guillemot D, et al
    Novel EWSR1::UBP1 fusion expands the spectrum of spindle cell rhabdomyosarcomas.
    Genes Chromosomes Cancer. 2022;61:200-205.
    PubMed     Abstract available

    January 2022
  4. KAZDAL D, Hofman V, Christopoulos P, Ilie M, et al
    Fusion-positive non-small cell lung carcinoma: Biological principles, clinical practice and diagnostic implications.
    Genes Chromosomes Cancer. 2022 Jan 8. doi: 10.1002/gcc.23022.
    PubMed     Abstract available

    October 2021
  5. KANG J, Deng QM, Peng KC, Li P, et al
    Clinicopathological features and resistance mechanism in HIP1-ALK-rearranged lung cancer: A multicenter study.
    Genes Chromosomes Cancer. 2021 Oct 23. doi: 10.1002/gcc.23005.
    PubMed     Abstract available

    February 2021
  6. PTAKOVA N, Martinek P, Holubec L, Janovsky V, et al
    Identification of tumors with NRG1 rearrangement, including a novel putative pathogenic UNC5D-NRG1 gene fusion in prostate cancer by data-drilling a de-identified tumor database.
    Genes Chromosomes Cancer. 2021 Feb 13. doi: 10.1002/gcc.22942.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Lung Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.